References
- The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1993; 153(2)154–183
- DeQuattro V. Benazepril compared with other antihypertensive agents, singly and in combination - a review. Benazepril: Profile of a New Ace Inhibitor, R. H. Brunner, A. Salvetti, S. P. Sever. Royal Society of Medicine Services, Ltd. 1990
- Frishman W H, Bryzinski B S, Coulson L R, et al. A multifactorial trial design to assess combination therapy in hypertension. Arch Int Med. 1994; 154: 1461–1468
- Egashira K, Pipers F S, Rush J, Morgan J P. Effects of calcium channel blockers on coronary vasoconstriction induced by endothelin-1 in closed chest pigs. JACC 1990; 16(5)1296–1303
- Clozel M, Kuhn H, Fefti F. Effects of angiotensin converting enzyme inhibitors and of hydrazaline on endothelial function in hypertensive rats. Hypertension 1990; 16: 532–540
- Bond M G, Strickland H L, Wilmoth S K, et al. Interventional clinical trials using noninvasive ultrasound end points: The Multicenter Isradipine/Diuretic Atherosclerosis Study. J Cardiovasc Pharm. 1990; 15(Suppl 1)S30–S30
- Weber K T, Sun Y. Structural remodeling in hypertensive heart disease and the role of hormones. Hypertension 1994; 23: 869–877
- Asmar R G, Iannascoli F, Benetos A, Safar M E. Dose optimization study of arterial changes associated with angiotensin converting enzyme inhibition in hypertension. J of Hypertension 1992, Suppl 5: S13–S19.
- McVeigh G E, Burns D E, Finkelstein S M, et al. Reduced vascular compliance as a marker for essential hypertension. Am J Hypertension 1991; 4: 1–7
- O'Rourke M. Arterial mechanics and wave reflection with antihypertensive therapy. J of Hypertension 1992; 10(Suppl 5)S43–S43
- Dahlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. Am J Hypertens 1992; 5: 95–110
- Kramer B L, Massie B M, Topic N. Controlled trial of captopril in CHF. Circulation 1983; 4: 807–816
- Petrella R J, Nichol P M, Cunningham D A, et al. Verapamil improves left ventricular filling and exercise performance in hypertensive and normotensive elderly individuals. Can J Cardiol 1994; 10: 973–981
- Kasiske B, Kalil R, Ma J, et al. Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis. Ann Int Med. 1993; 118: 129–138
- Bakris G, Barnhill B, Sadler R. Treatment of arterial hypertension in diabetic humansImportance of therapeutic selection. Kidney Int. 1992; 41: 912–919
- Munter K, Safer A, Gries J, et al. Antihypertensive effect of verapamil-trandolapril combination in hypertensive rats. Am J Hypertension 1995; 8: 175A–185A
- Munter K, Gries J, Hergenroder S, et al. Effect of a verpamil-trandolapril combination on hypertension, renal failure and survival of SHRSP. Am J Hypertension 1995; 8(4 Pt 2)176A.
- Snappin S M. Evaluating the efficacy of a combination therapy. Statistics in Med 1987; 6: 657–665
- Saunders E, Weir M R, Kong W, et al. A comparison of the efficacy and safety of a β-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Int Med. 1990; 150: 1707–1713
- Cesarone M R, deSantis M T, Laurora G, Belcaro G. Effect of trandolapril on 24-h ambulatory blood pressure in patients with mild to moderate hypertension. J Cardiovasc Pharmacol. 1994; 23(Suppl 4)S65–S65
- Jain A K, McMahon F G. 24-Hour Blood pressure response to two slow-release verapamil formulations in patients with mild to moderate hypertension. Cardiovasc Reviews & Reports. 1993; 14(4)45–51
- DeQuattro V. Individualization of therapy for hypertension in the 1990's: The role of calcium antagoists. Clin & Exper Hypertension 1994; 16(6)853–864